0001437749-21-016341.txt : 20210702
0001437749-21-016341.hdr.sgml : 20210702
20210702160539
ACCESSION NUMBER: 0001437749-21-016341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hohneker John
CENTRAL INDEX KEY: 0001695378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 211069950
MAIL ADDRESS:
STREET 1: C/O DIMENSION THERAPEUTICS, INC.
STREET 2: 840 MEMORIAL DRIVE 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-07-01
0001513818
Aravive, Inc.
ARAV
0001695378
Hohneker John
C/O ARAVIVE, INC., RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
1
Stock Options
5.80
2021-07-01
4
A
0
15435
0
A
2021-07-01
2031-06-30
Common Stock
15435
15435
D
Stock Options
5.80
2021-07-01
4
A
0
5245
0
A
2021-07-01
2031-06-30
Common Stock
5245
5245
D
Consists of options to purchase 15,435 shares of the Corporation's common stock, with immediate vesting as to 858 shares and 14,577 shares vesting pro rata over 34 months commencing on the one-month anniversary of the date of grant.
Consists of options to purchase 5,245 shares of the Corporation's common stock, with immediate vesting as to 2,623 shares and 2,622 shares vesting on a monthly basis over two (2) months commencing on the one-month anniversary of the grant date with full vesting, if not fully vested at such time, on the date of the Corporation's next annual meeting of stockholders
/s/ Abel Svitavsky, Attorney-in-fact
2021-07-02